Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

ADSC-derived exosome-loaded in-situ photocrosslinkable GelMA hydrogels as a treatment strategy for wound healing.

Zhang J., Liu C., Xie X., Hu Y., Li X., Zhang Z.

Animal Study on Chronic Wound, published in Burns (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Burns (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40934639
DOI
10.1016/j.burns.2025.107668

Abstract (original English)

Adipose-derived mesenchymal stem cell exosomes (ADSC-Exos) show great promise in wound healing and cutaneous regeneration, but their therapeutic efficacy is limited by rapid systemic clearance, preventing sustained local action at the wound site. Gelatin methacryloyl (GelMA) is a photocrosslinking hydrogel with good biocompatibility and tunable mechanical properties. This study aimed to investigate the effects of GelMA hydrogels loaded with ADSC-Exos (GelMA/ADSC-Exos hydrogels) on the wound healing of full-thickness skin defects. GelMA/ADSC-Exos hydrogels were prepared, and their physical and sustained-release properties were investigated. To assess the effect of GelMA/ADSC-Exos hydrogels on angiogenesis in vitro, the abilities of proliferation, migration, and tube formation of on human umbilical vein endothelial cells (HUVECs) cultured on GelMA/ADSC-Exos hydrogels were assayed. The effect of GelMA/ADSC-Exo hydrogels on wound healing was assessed using a mouse full-thickness excisional skin wound model. To elucidate the underlying mechanism, RNA sequencing was performed, and the effect of GelMA/ADSC-Exo hydrogels on the activity of macrophages was confirmed in vitro. The composite GelMA/ADSC-Exo hydrogels exhibited desirable mechanical and sustained release properties. They accelerated HUVEC proliferation, adhesion, and tube formation, as well as promoted wound healing in mice

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsWound HealingHydrogelsMiceGelatinExosomesHumansMesenchymal Stem CellsHuman Umbilical Vein Endothelial CellsMethacrylates

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research